Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5

This study has been terminated.

( This study was stopped by the sponsor based on a non-safety related corporate decision )

Study NCT00452478 Information provided by Shire Pharmaceutical Development

First Received: March 23, 2007 Last Updated: December 18, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2007
Estimated Primary Completion Date:	No date given